Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Can a phone app shield new mothers from postpartum depression?

NCT ID NCT06365645

Prevention Sponsor: Women and Infants Hospital of Rhode Island Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Aug 19, 2026 · Last updated Aug 20, 2026 · Updated 1 time

Summary

This trial is testing whether a smartphone app called M.Bapp, which delivers cognitive behavioral therapy, is a feasible and acceptable way to prevent postpartum depression in mothers at high risk. The study will enroll pregnant women who are at least 32 weeks along and have no recent history of depression or anxiety. Participants will be randomly assigned to use M.Bapp or a standard parenting education app, and researchers will measure how many women use the app and how satisfied they are with it.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
M.Bapp, a smartphone app delivering cognitive behavioral therapy content
What this could lead to
If effective, this app could offer a scalable, accessible way to prevent postpartum depression in at-risk mothers, potentially reducing the burden of this condition.
What could go wrong
This is an early feasibility study with a small sample, so it may not prove the app's effectiveness. The app's success depends on user engagement and satisfaction, which may vary.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

90 people

The number who actually took part.

Started

Jun 2024

Finished

Jun 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 60 years

Sex

Female participants only

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * English- or Spanish-speaking * maternal age \>18 years old * smartphone ownership * receiving prenatal care from a resident or nurse-practitioner/midwifery clinic at the Obstetric and Gynecologic Care Center at WIH * plan to receive postpartum care at the OGCC, * gestational age ≥32 weeks'. Exclusion Criteria: * Active diagnosis or history within five years of depression, anxiety, or other psychiatric condition, as documented in the electronic medical record * Endorsing active suicidality on intake survey or screening positive on EPDS (≥10) or Patient Health Questionnaire (PHQ)-9 (≥10) or GAD-7 (≥8) * prisoners * inability to consent.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Postpartum anxiety are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

Alzheimer disease postpartum depression prevention target

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Postpartum anxiety Postpartum depression Stress

Contacts and locations

Locations

  • Women & Infants Hospital of Rhode Island

    Providence, Rhode Island, 02905, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.